Literature DB >> 14769701

Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.

Martin Penicka1, Jozef Bartunek, Bernard De Bruyne, Marc Vanderheyden, Marc Goethals, Marc De Zutter, Pedro Brugada, Peter Geelen.   

Abstract

BACKGROUND: Cardiac resynchronization therapy was shown to reverse left ventricular (LV) remodeling in patients with congestive heart failure (CHF). However, the prediction of benefit is controversial. We aimed to investigate predictive factors of LV functional recovery and reversed remodeling after biventricular pacing. METHODS AND
RESULTS: Forty-nine consecutive patients with CHF and a wide QRS complex (182+/-32 ms) were studied by echocardiography before resynchronization. Intraventricular and interventricular asynchrony and their combination were assessed by pulsed-wave tissue Doppler imaging from measurements of regional electromechanical coupling times in basal segments of the right and left ventricle. At 6-month follow-up, responders were defined by a relative increase in LV ejection fraction > or =25% compared with baseline (n=27). Receiver operating curve analysis revealed the degree of intraventricular asynchrony (area under the curve=0.77), interventricular asynchrony (area under the curve=0.69), and their combination (area under the curve=0.84) as the best predictors of functional recovery after resynchronization. In addition, the degree of intraventricular and interventricular asynchrony correlated significantly with the improvement of LV ejection fraction (r=0.73, P<0.0001), end-diastolic diameter (r=-0.59, P<0.0001), and end-systolic diameter (r=-0.48, P<0.001) at follow-up. QRS duration and conventional echo-Doppler indices were not predictive of reversed LV remodeling.
CONCLUSIONS: In patients with CHF, the degree of intraventricular and interventricular asynchrony and their combination are the best predictive factors of LV functional recovery and reversed remodeling after cardiac resynchronization therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769701     DOI: 10.1161/01.CIR.0000116765.43251.D7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  71 in total

1.  Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.

Authors:  David Birnie; Rob A de Kemp; Anthony S Tang; Terence D Ruddy; Michael H Gollob; Ann Guo; Kathryn Williams; Kerry Thomson; Jean N DaSilva; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2011-12-10       Impact factor: 5.952

2.  SPECT blood pool phase analysis can accurately and reproducibly quantify mechanical dyssynchrony.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Richard W Wassenaar
Journal:  J Nucl Cardiol       Date:  2010-04-29       Impact factor: 5.952

Review 3.  Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy.

Authors:  C M Yu; J J Bax; M Monaghan; P Nihoyannopoulos
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

4.  The interaction of interventricular pacing intervals and left ventricular lead position during temporary biventricular pacing evaluated by tissue Doppler imaging.

Authors:  R E Lane; A W C Chow; J Mayet; D P Francis; N S Peters; R J Schilling; D W Davies
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

5.  FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.

Authors:  C M C van Campen; Frans C Visser; Arno P van der Weerdt; Paul Knaapen; Emile F I Comans; Adriaan A Lammertsma; Carel C de Cock; Cees A Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-26       Impact factor: 9.236

Review 6.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 7.  Optimal use of echocardiography in cardiac resynchronisation therapy.

Authors:  Gabe B Bleeker; Cheuk-Man Yu; Petros Nihoyannopoulos; Johan de Sutter; Nico Van de Veire; Eduard R Holman; Martin J Schalij; Ernst E van der Wall; Jeroen J Bax
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

Review 8.  Assessing right ventricular function: the role of echocardiography and complementary technologies.

Authors:  G B Bleeker; P Steendijk; E R Holman; C-M Yu; O A Breithardt; T A M Kaandorp; M J Schalij; E E van der Wall; P Nihoyannopoulos; J J Bax
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

9.  Association of corrected QT dispersion with symptoms improvement in patients receiving cardiac resynchronization therapy.

Authors:  Kazuyoshi Hina; Hiroshi Kawamura; Takashi Murakami; Keizo Yamamoto; Hirosuke Yamaji; Masaaki Murakami; Satoshi Hirohata; Hiroko Ogawa; Kohsuke Sakane; Shozo Kusachi
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

10.  Quantifying the role of regional dyssynchrony on global left ventricular performance.

Authors:  Bouchra Lamia; Masaki Tanabe; Hyung Kook Kim; Lauren Johnson; John Gorcsan; Michael R Pinsky
Journal:  JACC Cardiovasc Imaging       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.